Pyxis Tankers (PXS) – Outstanding quarter shows sensitivity to shipping rates

Tuesday, August 09, 2022

Pyxis Tankers (PXS)
Outstanding quarter shows sensitivity to shipping rates

We currently own a modern fleet of five tankers engaged in seaborne transportation of refined petroleum products and other bulk liquids. We are focused on growing our fleet of medium range product tankers, which provide operational flexibility and enhanced earnings potential due to their “eco” features and modifications. We are positioned to opportunistically expand and maximize our fleet due to competitive cost structure, strong customer relationships and an experienced management team whose interests are aligned with those of its shareholders. For more information, visit: http://www.pyxistankers.com.

Michael Heim, CFA, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Pyxis reported strong top-line results due to higher shipping rates. Results carried through to earnings. Pyxis reported 2022-2Q net revenues of $16.1 million vs. $7.7 million for the same period last year as higher energy prices and a disruption in global oil flow routes due to the Russia/Ukraine war resulted in higher tanker shipping rates. The average TCE rate for the quarter was $21,070 vs. $12,280 and could go higher in the third quarter with 57% of capacity fixed at $30,500. Meanwhile, operating costs per day declined to $6,181 from $6,697 leading to net income of $4.6 million or $0.38 per diluted versus ($1.4 million) or ($0.16 per share).

Cash flow is strong and the balance sheet is reasonable. Adjusted EBITDA was $7.3 million up from $0.4 million. The company’s cash position has grown to $6.2 million with $73.8 million in debt. Debt represents approximately 60% of capitalization (net debt is 55%). Debt is well supported by a increasingly more valuable asset base. Financing costs are an average 4.6%. The utilization rate for the quarter was 98%, a large improvement above first quarter rates of 74% that suffered from the accidental grounding of a tanker….

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Tonix Pharmaceuticals (TNXP) – Second Quarter Saw Progress In Several Therapeutic Areas

Tuesday, August 09, 2022

Tonix Pharmaceuticals (TNXP)
Second Quarter Saw Progress In Several Therapeutic Areas

Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Tonix’s portfolio is composed of immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. Tonix’s immunology portfolio includes biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-15001 which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. A Phase 1 study of TNX-1500 is expected to be initiated in the second half of 2022. Tonix’s rare disease portfolio includes TNX-29002 for the treatment of Prader-Willi syndrome. TNX-2900 has been granted Orphan-Drug Designation by the FDA. Tonix’s infectious disease pipeline includes a vaccine in development to prevent smallpox and monkeypox called TNX-8013, next-generation vaccines to prevent COVID-19, and an antiviral to treat COVID-19. Tonix’s lead vaccine candidates for COVID-19 are TNX-1840 and TNX-18504, which are live virus vaccines based on Tonix’s recombinant pox vaccine (RPV) platform. TNX-35005 (sangivamycin, i.v. solution) is a small molecule antiviral drug to treat acute COVID-19 and is in the pre-IND stage of development. TNX-102 SL6, (cyclobenzaprine HCl sublingual tablets), is a small molecule drug being developed to treat Long COVID, a chronic post-acute COVID-19 condition. Tonix expects to initiate a Phase 2 study in Long COVID in the second quarter of 2022. The Company’s CNS portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. Tonix’s lead CNS candidate, TNX-102 SL, is in mid-Phase 3 development for the management of fibromyalgia with a new Phase 3 study launched in the second quarter of 2022. Finally, TNX-13007 is a biologic designed to treat cocaine intoxication that is expected to start a Phase 2 trial in the second quarter of 2022. TNX-1300 has been granted Breakthrough Therapy Designation by the FDA.

Robert LeBoyer, Vice President, Research Analyst, Life Sciences , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

2Q Reported With Product Milestones Ahead.  Tonix reported a loss of $27.4 million or $(1.22) per share compared with our estimated loss of $26.9 million or $(1.43) per share.  During the quarter the company raised $28.5 million in a private placement, ending with $145.5 million in cash on June 30.

Monkeypox Program Has Become A New Focus.  Tonix announced that it formed a collaboration with the Kenya Medical Research Institute for a Phase 1 trial to start in 1H2023.   Tonix has been developing TNX-801, a vaccine that has been shown to be effective against both smallpox and monkeypox in preclinical testing with non-human primates.  We have always seen the potential for TNX-801 as an improved smallpox vaccine that would be sold to the US government stockpile for use defense against bioterrorism.  Since Monkeypox has been declared a public health emergency, monkeypox prevention could bring additional sales beyond our estimates….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Kandi Technologies Group, Inc. (KNDI) – The shift towards off-road vehicles accelerates

Tuesday, August 09, 2022

Kandi Technologies Group, Inc. (KNDI)
The shift towards off-road vehicles accelerates

Kandi Technologies Group, Inc. (KNDI), headquartered in Jinhua Economic Development Zone, Zhejiang Province, is engaged in the research, development, manufacturing, and sales of various vehicular products. Kandi conducts its primary business operations through its wholly-owned subsidiary, Zhejiang Kandi Technologies Group Co., Ltd. (“Zhejiang Kandi Technologies”), formerly, Zhejiang Kandi Vehicles Co., Ltd.) and its subsidiaries including Zhejiang Kandi Smart Battery Swap Technology Co., Ltd, and SC Autosports, LLC (d/b/a Kandi America), the wholly-owned subsidiary of Kandi in the United States, and its wholly-owned subsidiary, Kandi America Investment, LLC. Zhejiang Kandi Technologies has established itself as one of China’s leading manufacturers of pure electric vehicle parts and off-road vehicles.

Michael Heim, CFA, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Off-road vehicle sales rose 80% as the company continues to shift towards golf carts, go-karts, and ATVS. Off-road vehicle sales carry higher gross margins (10-15%) than other businesses. Management indicates that crossover golf carts delivered from the factory have increased from dozens in March 2022 to more than 2,000/month. Management believes the off-road market could be a $2.2 billion market by 2028, demonstrating 19% annual growth. Kandi plans on introducing new models this fall to stay ahead of demand. Battery sales (following an acquisition earlier this year) were also strong and contributing to profitability. 

Kandi is deemphasizing the electric vehicle market and seeing a slow down in scooters/bikes. Management continues to believe the EV market is currently too competitive stating that competitors are losing up to $10,000/vehicle to gain market share. Scooters/bikes sales, which were especially strong during COVID, declined 90% year over year as demand for the product drops….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Release – Tonix Pharmaceuticals to Present at the 2022 Virtual Q3 Investor Summit



Tonix Pharmaceuticals to Present at the 2022 Virtual Q3 Investor Summit

Research, News, and Market Data on Tonix Pharmaceuticals

August 09, 2022 7:00am EDT

CHATHAM, N.J., Aug. 09, 2022 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals, will present at the Virtual Q3 Investor Summit on Tuesday, August 16, 2022, at 9:30 a.m. ET.

Investors interested in arranging a meeting with the Company’s management during the conference should contact the Investor Summit conference coordinator. A webcast of the presentation can be found 
here and will be available under the IR Events tab of the Tonix website at www.tonixpharma.com.

About Tonix Pharmaceuticals
Holding Corp.
*

Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s portfolio is composed of central nervous system (CNS), rare disease, immunology and infectious disease product candidates. Tonix’s CNS portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. Tonix’s lead CNS candidate, TNX-102 SL (cyclobenzaprine HCl sublingual tablet), is in mid-Phase 3 development for the management of fibromyalgia with a new Phase 3 study launched in the second quarter of 2022 and interim data expected in the first quarter of 2023. TNX-102 SL is also being developed to treat Long COVID, a chronic post-acute COVID-19 condition. Tonix expects to initiate a Phase 2 study in Long COVID in the third quarter of 2022. TNX-1300 (cocaine esterase) is a biologic designed to treat cocaine intoxication that is Phase 2 ready and has been granted Breakthrough Therapy designation by the FDA. TNX-1900 (intranasal potentiated oxytocin), a small molecule in development for chronic migraine, is expected to enter the clinic with a Phase 2 study in the first half of 2023. Tonix’s rare disease portfolio includes TNX-2900 (intranasal potentiated oxytocin) for the treatment of Prader-Willi syndrome. TNX-2900 has been granted Orphan Drug designation by the FDA. Tonix’s immunology portfolio includes biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. A Phase 1 study of TNX-1500 is expected to be initiated in the first half of 2023. Tonix’s infectious disease pipeline consists of a vaccine in development to prevent smallpox and monkeypox, next-generation vaccines to prevent COVID-19, and a platform to make fully human monoclonal antibodies to treat COVID-19. TNX-801, Tonix’s vaccine in development to prevent smallpox and monkeypox, also serves as the live virus vaccine platform or recombinant pox vaccine (RPV) platform for other infectious diseases. A Phase 1 study of TNX-801 is expected to be initiated in Kenya in the first half of 2023. Tonix’s lead vaccine candidate for COVID-19 is TNX-1850, a live virus vaccines based on Tonix’s recombinant pox live virus vector vaccine platform. A Phase 1 study of the COVID-19 vaccine is expected to be initiated in the second half of 2023.

*All of Tonix’s product candidates are investigational new drugs or biologics and have not been approved for any indication.

This press release and further information about Tonix can be found at www.tonixpharma.com.

Forward
Looking Statements

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as “anticipate,” “believe,” “forecast,” “estimate,” “expect,” and “intend,” among others. These forward-looking statements are based on Tonix’s current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, risks related to the failure to obtain FDA clearances or approvals and noncompliance with FDA regulations; delays and uncertainties caused by the global COVID-19 pandemic; risks related to the timing and progress of clinical development of our product candidates; our need for additional financing; uncertainties of patent protection and litigation; uncertainties of government or third party payor reimbursement; limited research and development efforts and dependence upon third parties; and substantial competition. As with any pharmaceutical under development, there are significant risks in the development, regulatory approval and commercialization of new products. Tonix does not undertake an obligation to update or revise any forward-looking statement. Investors should read the risk factors set forth in the Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the Securities and Exchange Commission (the “SEC”) on March 14, 2022, and periodic reports filed with the SEC on or after the date thereof. All of Tonix’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The information set forth herein speaks only as of the date thereof.

Contacts

Jessica Morris (corporate)
Tonix Pharmaceuticals
investor.relations@tonixpharma.com
(862) 799-8599

Olipriya Das, Ph.D. (media)
Russo Partners
Olipriya.Das@russopartnersllc.com
(646) 942-5588

Peter Vozzo (investors)
ICR Westwicke
peter.vozzo@westwicke.com
(443) 213-0505


Primary Logo

Source: Tonix Pharmaceuticals Holding Corp.

Released
August 9, 2022


Release – Kratos Receives $14 Million Tactical Jet Drone System Contract Award



Kratos Receives $14 Million Tactical Jet Drone System Contract Award

Research, News, and Market Data on Kratos Defense & Security Solutions

August 9, 2022 at 8:00 AM EDT

SAN DIEGO, Aug.
09, 2022
 (GLOBE NEWSWIRE) — Kratos
Defense & Security Solutions, Inc.
 (Nasdaq: KTOS), a leading
National Security Solutions provider, announced today that it has recently
received an approximate $14 million Tactical Jet
Drone
 contract award. Kratos is an industry leader in the
development, design and fielding of affordable, high-performance jet powered
unmanned aerial drone systems. Work under this new contract award will be
performed at secure Kratos facilities and at customer locations. Due to
competitive, security related and other considerations, no additional information
will be provided related to this new contract award.

Steve Fendley, President of Kratos Unmanned Systems Division, said, “Kratos today has a family of affordable, high performance, tactical jet drone systems flying, including Valkyrie, MAKO, Gremlins, Airwolf, and others. In 2015 Kratos demonstrated manned – unmanned teaming with Kratos high performance Mako jet drone systems flying with a manned fighter aircraft, with the Mako performing a series of autonomous and operator-supervised missions. Today’s contract award announcement continues Kratos’ industry leading position and the evolution of certain of Kratos’ highest performance, most capable unmanned aerial systems in the world today.”

About Kratos
Defense & Security Solutions

Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) develops and fields transformative, affordable technology, platforms and systems for United States National Security related customers, allies and commercial enterprises. Kratos is changing the way breakthrough technology for these industries are rapidly brought to market through proven commercial and venture capital backed approaches, including proactive research and streamlined development processes. At Kratos, affordability is a technology and we specialize in unmanned systems, satellite communications, cyber security/warfare, microwave electronics, missile defense, hypersonic systems, training, combat systems and next generation turbo jet and turbo fan engine development. For more information go to 
www.KratosDefense.com.

Notice Regarding Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Kratos and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Kratos undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Kratos believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Kratos in general, see the risk disclosures in the Annual Report on Form 10-K of Kratos for the year ended 
December 26, 2021, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the 
SEC by Kratos.

Press Contact: Yolanda White 858-812-7302 Direct

Investor Information:
877-934-4687

investor@kratosdefense.com


Primary Logo

Source: Kratos Defense & Security Solutions, Inc.

 


Release – V2X (Formerly Vectrus) Reports Strong Second Quarter 2022 Results



V2X (Formerly Vectrus) Reports Strong Second Quarter 2022 Results

Research, News, and Market Data on V2X

Company Release – 
8/9/2022

Important Note: On July 5, 2022, Vectrus, Inc. closed on the
merger with The Vertex Company (“the Transaction”) and in connection
with the closing was renamed V2X, Inc. “Reported results” reflect the
contributions of Vectrus, Inc. based on results prior to the close of the
Transaction, unless otherwise noted.

Vectrus Second Quarter Highlights:

  • Second quarter revenues of $498 million, up +6% Y/Y
  • Operating income (inclusive of V2X transaction expenses) of $15.0 million with a margin of 3.0%
  • Adjusted EBITDA1 of $24.7 million with a margin of 5.0%
  • Second quarter fully diluted EPS of $0.88; Adjusted diluted EPS1 of $1.41
  • Strong second quarter operating cash flow of $46 million

Guidance:

  • The V2X merger closed on July 5, 2022, creating a more diversified company generating approximately $3.6 billion in combined pro forma annual revenue
  • Establishing second-half 2022 guidance for V2X that reflects the contributions of both Vectrus and Vertex with a total revenue range of $1.90 to $1.94 billion, an Adjusted EBITDA1 range of $140 to $150 million, and an operating cash flow range of $130 to $150 million

MCLEAN, Va., Aug. 9, 2022 /PRNewswire/ — V2X, Inc. (NYSE:VVX) announced second quarter 2022 financial results. The second quarter 2022 results are based on Vectrus’ stand-alone financial metrics for the period ended July 1, 2022, and do not include contribution from The Vertex Company.

V2X (PRNewsfoto/V2X, Inc.)

Transaction
Update

“We’re excited to announce the successful combination of Vectrus and The Vertex Company, creating a larger, higher margin and more diversified, V2X,” said Chuck Prow, Chief Executive Officer of V2X.  “With 14,000 employees, $3.6 billion in pro forma annual revenue, and $290 million of Adjusted EBITDA, V2X is a leader in the operational segment of the federal services market providing converged solutions throughout the mission lifecycle of our clients most critical and enduring global missions.”

Prow continued, “V2X has a strong financial profile with significant free cash flow and long-term revenue visibility through several notable contract wins that are in the early stages of their lifecycle. These wins are reflected in the company’s trailing twelve-month awards of approximately $6 billion, which include two recent significant awards at Vertex, the Naval Test Wing Atlantic, a seven-year program valued at $850 million, and the Air Force Global Strike Command five-year contract valued at $130 million. This also includes $600 million of awards booked at Vectrus during the quarter that were driven by expansion and increased scope on existing programs as well as follow-on contracts. The strong velocity of awards has resulted in a significant backlog of approximately $12 billion that provides solid visibility over the next several years.”

“In summary, the financial and strategic attributes of V2X are compelling,” added Prow. “Our integration activities are well underway and the commitment to our clients, the missions we are privileged to support, and delivering results remains our focus.”

Vectrus
Second Quarter Results

“Second quarter results for stand-alone Vectrus were strong, propelled by top-line performance and favorable operating cash flow,” said Prow.  “During the quarter, revenue grew 6% year-over-year and 9% sequentially to $498 million. Revenue growth was driven by building on the momentum of programs in INDOPACOM and Europe, along with successful phase-in of new contracts, including the Logistics Readiness Center at Fort Benning,” said Prow.  “Each day, our global team of dedicated employees execute on our core programs while also bringing innovation and technology-oriented solutions to complex challenges throughout the mission lifecycle.”  

“With a high-level readiness to meet the needs of our clients, the team continued its support of several important missions during the quarter, including providing the DoD with urgent and compelling services for the European Deterrence Initiative,” said Prow. “We leveraged our rapid response capability and over 40-year history of operating in Europe to provide the DoD with unique services in support of this complex and ongoing mission. Additionally, achieving full operational capability on LOGCAP V Kwajalein, approximately a month and a half ahead of schedule, has helped to expand our footprint in the INDOPACOM region. Activity in the region remains robust and our position continues to expand. For example, we recently expanded our scope of responsibilities at Subic Bay in the Philippines.  This program is expected to run over the next eight years and provides strategic logistics services to the DoD.  Work content in the INDOPACOM region now represents 9% of total revenue, up 3% from last year, and positions us well to support the DoD in a full range of operations over the next ten years.”

“Adjusted EBITDA for the quarter was strong at $24.7 million or 5.0% margin.  Adjusted EBITDA increased sequentially $6.5 million and was driven by higher revenue volume and success on operational excellence initiatives.  We remain focused on margin improvement, and this quarter’s results reflect our ability to expand earnings even as we execute on several programs in the early phases of period of performance. As we have noted in the past, LOGCAP V is generating higher revenue volume with a greater amount of material and pass-through content that has a different margin complexion. However, our teams are focused on driving program efficiencies and improving margin rates through contract add-on work while working with clients to convert certain components of work to more advantageous contract structures.”

Prow concluded, “Our second quarter results demonstrate the Company’s success in achieving top-line growth through increased work scope on existing programs, expansion of capabilities, broadening our geographic footprint, and adding new clients.  As we embark on the Company’s new chapter as V2X, I am excited about the greater scale, market leadership, and enhanced portfolio of offerings with the Vectrus/Vertex combination.”

Second quarter 2022 revenue of $498.1 million was up $27.2 million year on year.  “Revenue grew 6% year-over-year, driven by our transition to full operational capability on LOGCAP V programs in Iraq and Kuwait late last year, and INDOPACOM this year. In addition, revenue benefitted from transitioning Fort Benning and volume associated with rapid response and contingency efforts,” said Susan Lynch, Senior Vice President and Chief Financial Officer. “This revenue growth demonstrates achievement of our enterprise goal of growing the business through contract expansion and portfolio diversity despite the headwinds associated with the withdrawal of the US military from Afghanistan,” added Lynch. 

Operating income was $15.0 million or 3.0% margin.  This includes M&A and integration related expenses of $5.9 million and amortization of acquired intangible assets of $2.1 million which were incurred in the quarter.  Adjusted operating income1 was $23.0 million or 4.6% margin, increasing sequentially by $6.4 million and 100 basis points.  Adjusted EBITDA1 was $24.7 million or 5.0% margin, increasing sequentially by $6.5 million and 100 basis points.  Adjusted EBITDA margin compares to $26.6 million or 5.6% in the prior year period. “The year-on-year margin change was influenced by the significant amount of revenue and contracts that are in the early stages of their lifecycle.  In aggregate, on average and over time, we expect to see improvement in the margin profile as we drive operational efficiencies and diversify into higher margin scopes of work,” said Lynch.

Fully diluted EPS for the second quarter of 2022 was $0.88 as compared to $1.35 in the prior year.  Fully diluted EPS in the quarter included the aforementioned M&A and integration related costs.  Adjusted diluted EPS1 was $1.41 in the quarter as compared to $1.52 in the prior year. The year-on-year change in Adjusted diluted EPS1 was primarily due to the above-mentioned change in Adjusted EBITDA1.

Cash generated from operating activities for the quarter was $46.0 million.  Through July 1, 2022, net cash from operating activities was $19.6 million, compared to net cash from operating activities of $14.0 million through the second quarter of 2021. Cash from operating activities through the first half of 2022 was negatively impacted by an approximately $8.0 million repayment of CARES Act tax deferrals and $5.8 million of merger-related payments.

Net debt on July 1, 2022, was $58.4 million, compared to $105.2 million on July 2, 2021.  Total debt on July 1, 2022, was $90.2 million, down $84.8 million from $175.0 million on July 2, 2021. Cash at quarter-end was $35.1 million.  Total consolidated indebtedness to consolidated EBITDA1 (total leverage ratio) was 1.09x compared to 1.76x at the same time last year.

Total backlog as of July 1, 2022, was $4.6 billion.  Funded backlog was $1.3 billion. 

V2X
Guidance

Lynch continued, “We are establishing second half 2022 guidance ranges for V2X, which includes the contribution from both Vectrus and The Vertex Company.”

V2X guidance for the second half (2H) 2022 is as follows:

$
millions, except for EBITDA margins and per share amounts

V2X 2H 2022 Guidance

Revenue

$1,900

to

$1,940

Adjusted EBITDA1

$140

to

$150

Adjusted Diluted Earnings Per Share 1

$1.94

to

$2.19

Net Cash Provided by Operating Activities

$130

to

$150

Forward-looking statements are based upon current expectations and are subject to factors that could cause actual results to differ materially from those suggested here, including those factors set forth in the Safe Harbor Statement below. 

Second Quarter 2022 Conference Call

Management will conduct a conference call with analysts and investors at 4:30 p.m. ET on Tuesday, August 9, 2022. U.S.-based participants may dial in to the conference call at 877-242-2259, while international participants may dial 416-981-9017. A live webcast of the conference call as well as an accompanying slide presentation will be available on the Vectrus Investor Relations website at https://app.webinar.net/P4Qe37VDnop.

A replay of the conference call will be posted on the V2X website shortly after completion of the call and will be available for one year. A telephonic replay will also be available through August 23, 2022, at 844-512-2921 (domestic) or 412-317-6671 (international) with passcode 22020062.    

Footnotes:

1 See “Key Performance Indicators and Non-GAAP Financial Measures” for descriptions and reconciliations.

About V2X

V2X is a leading provider of critical mission solutions and support to defense clients globally, formed by the 2022 merger of Vectrus and The Vertex Company to build on more than 120 combined years of successful mission support. The Company delivers a comprehensive suite of integrated solutions across the operations and logistics, aerospace, training and technology markets to national security, defense, civilian and international clients. Our global team of approximately 14,000 employees brings innovation to every point in the mission lifecycle, from preparation, to operations, to sustainment, as it tackles the most complex challenges with agility, grit, and dedication.

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 (the “Act”): Certain material presented herein includes forward-looking statements intended to qualify for the safe harbor from liability established by the Act. These forward-looking statements include, but are not limited to, all the statements and items listed in the table in “2022 Guidance” above and other assumptions contained therein for purposes of such guidance, other statements about our 2021 performance outlook, five-year growth plan, revenue, DSO, contract opportunities, the potential impact of COVID-19, and any discussion of future operating or financial performance.

Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “could,” “potential,” “continue” or similar terminology. These statements are based on the beliefs and assumptions of the management of the Company based on information currently available to management.

These forward-looking statements are not guarantees of future performance, conditions, or results, and involve a number of known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside our management’s control, that could cause actual results to differ materially from the results discussed in the forward-looking statements.  In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from the Company’s historical experience and our present expectations or projections. For a discussion of some of the risks and important factors that could cause actual results to differ from such forward-looking statements, see the risks and other factors detailed from time to time our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other filings with the U.S. Securities and Exchange Commission.

We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

V2X, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)

Three Months Ended

Six Months Ended

July 1,

July 2,

July 1,

July 2,

(In
thousands, except per share data)

2022

2021

2022

2021

Revenue

$      498,066

$             470,845

$         954,537

$         904,849

Cost of revenue

453,305

422,660

872,581

816,308

Selling, general, and administrative expenses

29,740

25,605

61,699

49,427

Operating income

15,021

22,580

20,257

39,114

Interest expense, net

(1,963)

(2,253)

(3,643)

(4,186)

Income from operations before income taxes

13,058

20,327

16,614

34,928

Income tax expense

2,586

4,393

3,287

6,946

Net income

$         10,472

$               15,934

$           13,327

$           27,982

Earnings per share

Basic

$           0.89

$                   1.36

$               1.13

$               2.40

Diluted

$           0.88

$                   1.35

$               1.12

$               2.37

Weighted average common shares
outstanding – basic

11,826

11,715

11,793

11,681

Weighted average common shares
outstanding – diluted

11,954

11,828

11,917

11,823

 

V2X, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

July 1,

December 31,

(In
thousands, except per share information)

2022

2021

Assets

Current assets

Cash and cash equivalents

$                   31,760

$                   38,513

Restricted cash

3,311

__—_

Receivables

374,980

348,605

Prepaid expenses

26,262

21,160

Other current assets

10,646

15,062

Total current assets

446,959

423,340

Property, plant, and equipment, net

23,530

23,758

Goodwill

321,734

321,734

Intangible assets, net

62,159

66,582

Right-of-use assets

39,705

43,651

Other non-current assets

11,760

10,394

Total non-current assets

458,888

466,119

Total Assets

$                 905,847

$                 889,459

Liabilities and Shareholders’ Equity

Current liabilities

Accounts payable

$                 244,080

$                 212,533

Compensation and other employee benefits

82,534

80,284

Short-term debt

10,400

10,400

Other accrued liabilities

48,322

55,031

Total current liabilities

385,336

358,248

Long-term debt, net

78,884

94,246

Deferred tax liability

32,489

32,214

Operating lease liability

30,719

34,536

Other non-current liabilities

14,941

20,128

Total non-current liabilities

157,033

181,124

Total liabilities

542,369

539,372

Commitments and contingencies (Note 9)

Shareholders’ Equity

Preferred stock; $0.01 par value; 10,000,000
shares authorized; No shares issued and outstanding

Common stock; $0.01 par value; 100,000 shares
authorized; 11,846 and 11,738 shares issued and
outstanding as of July 1, 2022, and December 31,
2021, respectively                                      

118

117

Additional paid in capital

91,464

88,116

Retained earnings

281,081

267,754

Accumulated other comprehensive loss

(9,185)

(5,900)

Total shareholders’ equity

363,478

350,087

Total Liabilities and Shareholders’ Equity

$                 905,847

$                 889,459

 

V2X, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

Six Months Ended

July 1,

July 2,

(In
thousands)

2022

2021

Operating activities

Net income

$              13,327

$              27,982

Adjustments to reconcile net income to net cash provided by
operating activities:

Depreciation expense

3,238

3,097

Amortization of intangible assets

4,423

4,891

(Gain) Loss on disposal of property, plant, and equipment

(15)

60

Stock-based compensation

4,725

4,923

Amortization of debt issuance costs

388

463

Changes in assets and liabilities:

Receivables

(29,302)

(38,882)

Prepaid expenses

(5,321)

(4,660)

Other assets

5,185

597

Accounts payable

32,470

18,784

Deferred taxes

370

Compensation and other employee benefits

2,507

11,285

Other liabilities

(11,989)

(14,884)

Net cash provided by operating activities

19,636

14,026

Investing activities

Purchases of capital assets

(3,492)

(4,833)

Proceeds from the disposition of assets

18

16

Business acquisition purchase price adjustment

262

Contribution to joint venture

(2,113)

(1,846)

Net cash used in investing activities

(5,587)

(6,401)

Financing activities

Repayments of long-term debt

(5,200)

(4,000)

Proceeds from revolver

392,000

215,000

Repayments of revolver

(402,000)

(215,000)

Proceeds from exercise of stock options

370

113

Payment of debt issuance costs

(458)

(17)

Payments of employee withholding taxes on share-based
compensation

(1,696)

(2,272)

Net cash used in financing activities

(16,984)

(6,176)

Exchange rate effect on cash

(507)

(373)

Net change in cash, cash equivalents and restricted cash

(3,442)

1,076

Cash, cash equivalents and restricted cash – beginning of year

38,513

68,727

Cash, cash equivalents and restricted cash – end of period

$              35,071

$              69,803

Supplemental disclosure of cash flow information:

Interest paid

$                3,409

$                3,111

Income taxes paid

$                6,112

$                5,747

Purchase of capital assets on account

$                    13

$                   618

Key Performance Indicators and Non-GAAP Measures

The primary financial performance measures we use to manage our business and monitor results of operations are revenue trends and operating income trends. Management believes that these financial performance measures are the primary drivers for our earnings and net cash from operating activities. Management evaluates its contracts and business performance by focusing on revenue, operating income, and operating margin. Operating income represents revenue less both cost of revenue and selling, general and administrative (SG&A) expenses. Cost of revenue consists of labor, subcontracting costs, materials, and an allocation of indirect costs, which includes service center transaction costs. SG&A expenses consist of indirect labor costs (including wages and salaries for executives and administrative personnel), bid and proposal expenses and other general and administrative expenses not allocated to cost of revenue. We define operating margin as operating income divided by revenue.

We manage the nature and amount of costs at the program level, which forms the basis for estimating our total costs and profitability. This is consistent with our approach for managing our business, which begins with management’s assessing the bidding opportunity for each contract and then managing contract profitability throughout the performance period.

In addition to the key performance measures discussed above, we consider adjusted operating income, adjusted operating margin, adjusted net income, adjusted diluted earnings per share, EBITDA, adjusted EBITDA, EBITDA margin, adjusted EBITDA margin, and organic revenue to be useful to management and investors in evaluating our operating performance, and to provide a tool for evaluating our ongoing operations. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives. We provide this information to our investors in our earnings releases, presentations, and other disclosures.

Adjusted operating income, adjusted operating margin, adjusted net income, adjusted diluted earnings per share, EBITDA, adjusted EBITDA, EBITDA margin, adjusted EBITDA margin, and organic revenue, however, are not measures of financial performance under GAAP and should not be considered a substitute for operating income, operating margin, net income, and diluted earnings per share as determined in accordance with GAAP.  Definitions and reconciliations of these items are provided below.

  • Adjusted
    operating income
     is defined as operating income, adjusted to exclude items that may include, but are not limited to significant charges or credits, and unusual and infrequent non-operating items, such as M&A, integration and related costs, LOGCAP V pre-operational legal costs, and amortization of acquired intangible assets that impact current results but are not related to our ongoing operations.
  • Adjusted
    operating margin
     is defined as adjusted operating income divided by revenue.
  • Adjusted
    net income
     is defined as net income, adjusted to exclude items that may include, but are not limited to, significant charges or credits, and unusual and infrequent non-operating items, such as M&A, integration and related costs, LOGCAP V pre-operational legal costs, and amortization of acquired intangible assets that impact current results but are not related to our ongoing operations.
  • Adjusted
    diluted earnings per share
     is defined as adjusted net income divided by the weighted average diluted common shares outstanding.
  • EBITDA is defined as operating income, adjusted to exclude depreciation and amortization.
  • Adjusted
    EBITDA
     is defined as EBITDA, adjusted to exclude items that may include, but are not limited to, significant charges or credits and unusual and infrequent non-operating items, such as M&A, integration and related costs, LOGCAP V pre-operational legal costs that impact current results but are not related to our ongoing operations.
  • EBITDA
    margin
     is defined as EBITDA divided by revenue.
  • Adjusted
    EBITDA margin
     is defined as Adjusted EBITDA divided by revenue.

 

Adjusted Net Income, Adjusted Diluted Earnings Per
Share (Non-GAAP Measures)

($K,
except per share data)

Three Months
Ended July
01, 2022 As
Reported

M&A,
Integration

and Related
Costs

LOGCAP V
Pre-

Operational

Legal Costs

Amortization
of Acquired
Intangible

Assets

Three
Months

Ended July
01, 2022 –
Adjusted

Revenue

$       498,066

$                      —

$                     —

$                     —

$       498,066

Growth

5.8 %

5.8 %

Operating income

$         15,021

$                5,879

$                     —

$          2,122

$         23,022

Operating margin

3.0 %

4.6 %

Interest expense, net

$          (1,963)

$                      —

$                     —

$                     —

$          (1,963)

Income from operations before income taxes

$            13,058

$                5,879

$                     —

$               2,122

$         21,059

Income tax expense

$               2,586

$                1,164

$                     —

$                  420

$           4,170

Income tax rate

19.8 %

19.8 %

Net income

$            10,472

$                4,715

$                     —

$               1,702

$         16,889

Weighted average common shares outstanding, diluted

11,954

11,954

Diluted earnings per share

$              0.88

$                  0.39

$                     —

$                 0.14

$             1.41

EBITDA (Non-GAAP Measures)

($K)

Three Months
Ended July
01, 2022 As
Reported

M&A,
Integration

and Related
Costs

LOGCAP V
Pre-

Operational

Legal Costs

Amortization
of Acquired
Intangible

Assets

Three
Months

Ended July
01, 2022 –
Adjusted

Operating Income

$         15,021

$                5,879

$                     —

$               2,122

$         23,022

Add:

Depreciation and amortization

$        3,769

$                      —

$                     —

$               (2,122)

$           1,647

EBITDA

$         18,790

$                5,879

$                     —

$                     —

$         24,669

EBITDA Margin

3.8 %

5.0 %

 

Adjusted Net Income, Adjusted Diluted Earnings Per
Share (Non-GAAP Measures)

($K,
except per share data)

Three Months
Ended July
02, 2021 As
Reported

M&A,
Integration

and Related
Costs

LOGCAP V
Pre-

Operational

Legal Costs

Amortization
of Acquired
Intangible Assets

Three Months
Ended July
02, 2021 –
Adjusted

Revenue

$       470,845

$                     —

$                     —

$                     —

$       470,845

Operating income

$      22,580

$                     —

$                   21

$               2,436

$         25,037

Operating margin

4.8 %

5.3 %

Interest expense, net

$          (2,253)

$                     —

$                     —

$                     —

$          (2,253)

Income from operations before income taxes

$         20,327

$                     —

$                   21

$               2,436

$         22,784

Income tax expense

$            4,393

$                     —

$                     4

$                   463

$           4,860

Income tax rate

21.6 %

21.3 %

Net income

$         15,934

$                     —

$                   17

$               1,973

$         17,924

Weighted average common shares outstanding, diluted

11,828

11,828

Diluted earnings per share

$              1.35

$                     —

$                 0.00

$                 0.17

$              1.52

EBITDA (Non-GAAP Measures)

($K)

Three Months
Ended July
02, 2021 As
Reported

M&A,
Integration

and

Related Costs

LOGCAP V
Pre-

Operational

Legal Costs

Amortization
of Acquired
Intangible Assets

Three Months
Ended July
02, 2021 –
Adjusted

Operating Income

$         22,580

$                     —

$                   21

$               2,436

$         25,037

Add:

Depreciation and amortization

$            3,991

$                     —

$                     —

$            (2,436)

$           1,555

EBITDA

$         26,571

$                     —

$                   21

$                     —

$         26,592

EBITDA Margin

5.6 %

5.6 %

 

Adjusted Net Income, Adjusted Diluted Earnings Per
Share (Non-GAAP Measures)

($K,
except per share data)

Six Months
Ended July
01, 2022 As
Reported

M&A,
Integration and
Related Costs

LOGCAP V
Pre-

Operational

Legal Costs

Amortization
of Acquired
Intangible Assets

Six Months
Ended July
01, 2022 –
Adjusted

Revenue

$       954,537

$                     —

$                     —

$                     —

$      954,537

Growth

5.5 %

5.5 %

Operating income

$         20,257

$             14,947

$                   —

$               4,423

$        39,627

Operating margin

2.1 %

4.2 %

Interest expense, net

$          (3,643)

$                     —

$                     —

$                     —

$         (3,643)

Income from operations before income taxes

$         16,614

$             14,947

$                   —

$               4,423

$        35,984

Income tax expense

$            3,287

$               2,957

$                     —

$                    875

$          7,119

Income tax rate

19.8 %

19.8 %

Net income

$              13,327

$             11,990

$                   —

$               3,548

$        28,865

Weighted average common shares outstanding, diluted

11,917

11,917

Diluted earnings per share

$              1.12

$                 1.01

$                 —

$                 0.30

$             2.42

EBITDA (Non-GAAP Measures)

($K)

Six Months
Ended July
01, 2022 As
Reported

M&A,
Integration and
Related Costs

LOGCAP V
Pre-

Operational

Legal Costs

Amortization
of Acquired
Intangible Assets

Six Months
Ended July
01, 2022 –
Adjusted

Operating Income

$         20,257

$             14,947

$                   —

$               4,423

$        39,627

Add:

Depreciation and amortization

$            7,661

$                     —

$                     —

$                (4,423)

$            3,238

EBITDA

$         27,918

$             14,947

$                   —

$                     —

$        42,865

EBITDA Margin

2.9 %

4.5 %

 

Adjusted Net Income, Adjusted Diluted Earnings Per
Share (Non-GAAP Measures)

($K,
except per share data)

Six Months
Ended July
02, 2021 As
Reported

M&A,
Integration and
Related Costs

LOGCAP V
Pre-

Operational

Legal Costs

Amortization
of Acquired
Intangible Assets

Six Months
Ended July
02, 2021 –
Adjusted

Revenue

$      904,849

$                    —

$                    —

$                    —

$      904,849

Operating income

$        39,114

$                     —

$                 178

$              4,891

$        44,183

Operating margin

4.3 %

4.9 %

Interest expense, net

$         (4,186)

$                    —

$                    —

$                    —

$         (4,186)

Income from operations before income taxes

$        34,928

$                     —

$                 178

$              4,891

$        39,997

Income tax expense

$          6,946

$                     —

$                   34

$                 929

$          7,909

Income tax rate

19.9 %

19.9 %

Net income

$        27,982

$                     —

$                 144

$              3,962

$        32,088

Weighted average common shares outstanding, diluted

11,823

11,823

Diluted earnings per share

$             2.37

$                     —

$                0.01

$                0.33

$             2.71

EBITDA (Non-GAAP Measures)

($K)

Six Months
Ended July
02, 2021 As
Reported

M&A,
Integration and
Related Costs

LOGCAP V
Pre-

Operational

Legal Costs

Amortization
of Acquired
Intangible Assets

Six Months
Ended July
02, 2021 –
Adjusted

Operating Income

$        39,114

$                     —

$                 178

$              4,891

$        44,183

Add:

Depreciation and amortization

$          7,988

$                    —

$                    —

$           (4,891)

$          3,097

EBITDA

$        47,102

$                     —

$                 178

$                    —

$        47,280

EBITDA Margin

5.2 %

5.2 %

 

 

SUPPLEMENTAL INFORMATION

Revenue by client branch, contract type, contract relationship, and geographic region for the periods presented below was as follows: 

Revenue
by Client

Three Months Ended

Six Months Ended

July 1,

July 2,

July 1,

July 2,

(In
thousands)

2022

%

2021

%

2022

%

2021

%

Army

$    326,756

65 %

$    310,638

66 %

$     606,869

63 %

$      567,987

63 %

Air Force

68,457

14 %

63,206

13 %

129,930

14 %

141,375

16 %

Navy

64,885

13 %

56,399

12 %

140,102

15 %

112,827

12 %

Other

37,968

8 %

40,602

9 %

77,636

8 %

82,660

9 %

Total revenue

$    498,066

$    470,845

$     954,537

$      904,849

Revenue
by Contract Type

Three Months Ended

Six Months Ended

July 1,

July 2,

July 1,

July 2,

(In
thousands)

2022

%

2021

%

2022

%

2021

%

Cost-plus and cost-reimbursable

$    355,559

71 %

$    344,189

73 %

$     666,653

70 %

$      634,420

70 %

Firm-fixed-price

128,348

26 %

111,416

24 %

256,352

27 %

240,173

27 %

Time and material

14,159

3 %

15,240

3 %

31,532

3 %

30,256

3 %

Total revenue

$    498,066

$    470,845

$     954,537

$      904,849

Revenue
by Contract Relationship

Three Months Ended

Six Months Ended

July 1,

July 2,

July 1,

July 2,

(In
thousands)

2022

%

2021

%

2022

%

2021

%

Prime contractor

$    468,453

94 %

$    440,040

93 %

$     895,546

94 %

$      843,303

93 %

Subcontractor

29,613

6 %

30,805

7 %

58,991

6 %

61,546

7 %

Total revenue

$    498,066

$    470,845

$     954,537

$      904,849

Revenue
by Geographic Region

Three Months Ended

Six Months Ended

July 1,

July 2,

July 1,

July 2,

(In
thousands)

2022

%

2021

%

2022

%

2021

%

Middle East

$    250,222

50 %

$    258,488

55 %

$     485,313

51 %

$      498,500

55 %

United States

158,719

32 %

146,549

31 %

325,454

34 %

296,362

33 %

Europe

42,739

9 %

36,084

8 %

81,178

8 %

76,706

8 %

Asia

46,386

9 %

29,724

6 %

62,592

7 %

33,281

4 %

Total revenue

$    498,066

$    470,845

$     954,537

$      904,849

CONTACT: 
V2X, Inc. 
Mike Smith, CFA
719-637-5773

 


Release – Comstock Announces Second Quarter 2022 Results



Comstock Announces Second Quarter 2022 Results

Research, News, and Market Data on Comstock Mining

Cellulosic
Breakthrough Unlocks Massive New Feedstock Model for Net Zero Energy
Independence

VIRGINIA
CITY, NEVADA, AUGUST 9, 2022
 – Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”) today announced its recent business development highlights, second quarter 2022 results, and updated outlook.  

Selected Strategic Highlights – Cellulosic Fuels

  • Expanded our leading cellulosic fuels technology portfolio by filing for a new patent covering breakthrough pathways to produce Bioleum a renewable offset for petroleum and multiple drop-in renewable fuels from woody biomass.
  • Filed a preliminary application for a U.S. Department of Energy (“DOE”) grant opportunity for a pilot scale system to validate enhanced production metrics of purified bio-intermediaries and renewable fuels from woody biomass.
  • Received a notification of “encouragement” from the U.S. Department of Energy for this same grant opportunity.
  • Established strategic collaborations with leading industry partners, including feedstock and offtake relationships, for the development of renewable fuels, from woody biomass, at dramatically improved yield, efficiency, and cost.
  • Advanced the engineering and development of our cellulosic fuel demonstration facility.

Selected Strategic Highlights – Lithium Extraction
and Electrification Products

  • Commissioned our proprietarylithium-ion battery (“LIB”) pilot crushing, separation, and conditioning system.
  • Enhanced the design and commenced upgrades on our proprietary LIB pilot crushing and separation system.
  • Completed construction of our prototype lithium extraction system in our R&D facility and commenced testing.
  • Advanced permitting for our state-of-the-art battery metal recycling facility in Nevada.
  • Production of high-purity black mass to commence in our battery metal recycling facility by Q2 2023.
  • Production of battery grade lithium carbonate to commence in our battery metal recycling facility by Q3 2023.

Selected Financial Highlights

  • Total assets were $117,826,063 as of June 30, 2022, as compared to $115,119,393 at March 31, 2022.
  • Operating expenses were $5,896,617 for the second quarter 2022, including selling, general and administrative expenses of $2,508,573 and research and development expenses of $2,579,150, and depreciation of $808,894.
  • Second quarter 2022 net loss was $13,766,846 or $(0.20) per share, as compared to second quarter 2021 net loss of $6,320,992 or $(0.15) per share. The 2022 results were primarily driven by increases in research and development expenditures and changes in fair values of derivatives.
  • Advanced non-strategic asset monetization efforts with asset sales proceeds expected at $20 million. 
  • Debt was $4,572,356 on June 30, 2022, net of discount, representing an unsecured promissory note.
  • Cash and cash equivalents were $4,345,315 on June 30, 2022.
  • Outstanding common shares were 76,822,049 at June 30, 2022, and 78,737,632 at August 8, 2022.

“Our financial results reflect the impact of our continued investment in the research, development and commercialization of our renewable energy businesses,” said Corrado De Gasperis, Comstock’s executive chairman and chief executive officer. “The building and operating of these proprietary demonstration systems are critical prerequisites for full scale commercialization.”

Cellulosic Fuels

The Company recently announced a significant expansion of its leading cellulosic technology portfolio by filing for a new patent covering breakthrough pathways to produce renewable diesel, sustainable aviation fuel (“SAF”) gasoline and marine fuel from woody biomass, at dramatically improved yield, efficiency, and cost in comparison to all known methods.

Renewable fuels provide a critical opportunity for decarbonization, however, most of the existing U.S. renewable fuel refineries draw from the same limited pool of constrained feedstocks. Comstock’s plans to decarbonize with renewable fuels involves abundant feedstocks that are not used today, enabling a vast untapped energy source with superior benefits. 

“Our new patent covers processes and compositions that have been validated at our existing two ton per day cellulosic fuels pilot facility, verifying that we can simultaneously produce multiple purified biointermediates that are uniquely isolated and free of the contaminants that have frustrated prior attempts at commercializing cellulosic fuel technologies,” added De Gasperis.

Based on current data, Comstock projects best-in-class renewable yields exceeding 80 gallons per dry ton of woody biomass (on a gasoline gallon equivalent basis), with lifecycle greenhouse gas emissions reductions exceeding 80% over petroleum.

The Company is currently expanding its existing cellulosic demonstration systems to include the production of Bioleum™ and expects these demonstration systems to add to our existing capabilities for producing carbon-neutral pulps, cellulosic sugar and cellulosic ethanol.  The expansion into Bioleum™ will demonstrate the full capability of producing these bio-intermediaries suitable for the production of renewable diesel, marine, SAF and gasoline from woody biomass.

The Company recently submitted a preliminary grant application to the U.S. Department of Energy (“DOE”) entitled “Production of Renewable Diesel,
Sustainable Aviation Fuel, Gasoline, and Marine Fuel from Lignocellulosic
Biomass at Dramatically Improved Yield, Efficiency, and Cost” 
and received a DOE notification of encouragement to apply for this funding opportunity, reflecting positively on the Company technology readiness and the strength of its collaboration partners.

De Gasperis continued, “The existing U.S. biorefining capacity is far greater than current feedstocks can support, and the DOE clearly recognizes the need for expanded feedstocks. We believe that our expanded technology solutions, and the magnitude of feedstocks that they enable, unblock one of the most critical supply chain constraints across the U.S. and global markets.”

Electrification Products

The Company completed construction and initial commissioning of its breakthrough LIB crushing, separating, and conditioning process during the second quarter, successfully confirming the production of highly concentrated “black mass.”

“We have successfully developed a proprietary system that produces a novel and pure black mass, further positioning us for high efficiency metals extraction, starting with lithium,” said Mr. De Gasperis. “Our team is enhancing the pilot system for deployment in Nevada where we will ultimately integrate our black mass production and lithium extraction process in 2023.”  

The Company expects to receive its main operating permit during the fourth quarter of 2022 and complete the submission of its modified air quality permits for our LIB processes at our state-of-the-art, battery metal recycling facility in the third quarter.

“The cleaning and repairs of our facility in Nevada are near complete and truly look outstanding.  The facility can now be readied for the receipt and installations of pilot and demonstration units for crushing, separating and conditioning of our novel black mass and subsequently, our lithium extraction, while the permitting process continues” concluded Mr. De Gasperis.

Corporate

Cash and cash equivalents were $4,345,315 on June 30, 2022. The Company expects over $20 million in proceeds over the next two quarters from the sale of its non-mining properties, non-strategic investments, and collection of advances receivable, including the Daney Ranch for $2.5 million, net, and proceeds from Sierra Springs Opportunity Fund totaling over $18 million.

Conference Call Details

Comstock will host the conference call on Tuesday, August 9, 2022, at 1:15 p.m. PDT  (4:15 p.m. EDT) and the webcast will include a moderated question and answer session following the Company’s prepared remarks.  Please click the link below to register in advance and please join the event at least 10 minutes prior to the scheduled start time. Once registered, you will receive a confirmation email containing information about joining the Webcast. Please 
click here to register in advance.

About
Comstock

Comstock (NYSE: LODE) innovates technologies that contribute to global decarbonization and circularity by efficiently converting under-utilized natural resources into renewable fuels and electrification products that contribute to balancing global uses and emissions of carbon. The Company intends to achieve exponential growth and extraordinary financial, natural, and social gains by building, owning, and operating a fleet of advanced carbon neutral extraction and refining facilities, by selling an array of complimentary process solutions and related services, and by licensing selected technologies to qualified strategic partners. To learn more, please visit www.comstock.inc.

Forward-Looking
Statements 

This press release and any related calls or discussions may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, are forward-looking statements. The words “believe,” “expect,” “anticipate,” “estimate,” “project,” “plan,” “should,” “intend,” “may,” “will,” “would,” “potential” and similar expressions identify forward-looking statements, but are not the exclusive means of doing so. Forward-looking statements include statements about matters such as: future industry market conditions; future explorations or acquisitions; future changes in our exploration activities; future changes in our research and development; and future prices and sales of, and demand for, our products and services. Except as may be required by securities or other law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Neither this press release nor any related call or discussion constitutes an offer to sell, the solicitation of an offer to buy or a recommendation with respect to any securities of the Company, the fund or any other issuer.

  Contact
information:

 

 

Comstock Mining Inc.
P.O. Box 1118
Virginia City, NV 89440
www.comstock.inc

Corrado De Gasperis
Executive Chairman & CEO
Tel (775) 847-4755
degasperis@comstockmining.com

Zach Spencer
Director of External Relations
Tel (775) 847-5272 Ext.151
questions@comstockmining.com

 


Cathie Wood’s Expectations for Inflation, Recession, Markets, China, and Jobs



Image: Bloomberg TV (August 8, 2022)


Why Cathie Wood Thinks We Will Emerge from A Recession More Quickly than Others

Cathie Wood, the founder, and CIO of Ark Invest, was asked in an interview, “Is the Fed going to continue hiking rates, or are they going to stop and turn around and come back down next year?” Her response was not initially uplifting, but as she explained why her firm has evaluated the current economic growth trajectory and what the future may bring, the fund manager, that focuses on innovative sectors, was actually optimistic.


Are Jobs Strong?

Wood brought up July’s huge unexpected increase in Non-Farm Payroll and contrasted it with the Household Employment numbers (a broader-based survey). She reminded the Bloomberg interviewer that Household Employment “…has been flat to down for the last four months.”  She added, “If you look at [unemployment] claims, we’ve never seen a faster increase.” She thinks people don’t weigh in the fact that we are up 50% off the low in unemployment. Cathie Wood also mentioned that large numbers of people are being laid off, then she referenced a Challenger survey that reported layoffs are up 55-60% year-over-year.

The reason she gave for the layoffs is inventory levels. “We have a massive inventory glut.” She believes the push to hire is ending and unwinding.


Is Inflation a Non-Issue?

Cathie Wood had been on record as previously saying, “deflation is more of a concern than inflation.” She was asked if she still feels this way. “I still think that because the evidence is piling up. Now the CPI and to some measure the PPI, both of those are lagging indicators.” She emphasized, “The Fed is driving policy off lagging indicators.”

What she prefers to look at is the price of commodities used for building and growth like copper. She said that copper took a decisive break to the downside (20%), but the decrease hasn’t yet fed into the inflation indexes. Wood says a better measure of where inflation is headed is gold. “Prices [Gold] peaked August 2020, we’ve been in a trading range, we’re at the low end of the trading range now.” She believes if the Fed continues to tighten, her firm’s expectation is the dollar will turn back up, and commodities will continue
to fall
.

The next inflation report is due Wednesday (August 10). An Econoday consensus estimate puts July headline inflation at 8.7%, cooling from 9.1% in June.


Are We in a Recession?

“Yes, we believe we are in a recession.” Wood told the interviewer. She explained that the economy receded for two consecutive quarters, which is the beginning of the definition. Three consecutive declines in leading indicators would suggest the same, she explained. “Our point of view is this is going to be a severe inventory recession, but we don’t have the systemic excesses like we did pre-2008, 2009 in the mortgage market.” She explained that while many economists use the inverted yield curve and say it indicates a recession next year, she believes we will be coming out of our current recession next year.


What’s Going on in China?

Cathie Wood says the big question is what is going on in China? She offered that perhaps the commodity prices unraveling has to do with the Chinese economy, especially their growth-inhibiting policies and real estate problems. She thinks China’s economy is going to be more difficult for them to control than they anticipated.


Why Stay Invested?

She was asked if it makes sense to move to cash since there are possible trouble spots on the horizon. In classic, confident optimism, Cathie Wood responded, “We are going to stay 100% in innovation.” Her reason is innovation is going to be a critical allocation in the years ahead. She explained, “Innovation saves time. Innovation solves problems.” She then listed the current problems, as supply chain, and energy, and food price increases. “Better, cheaper, faster, more productive, more efficient, more creative, is going to win,”  she exclaimed.

Wood thinks most asset allocators are short the innovation categories. Her idea of the sector is not current day high tech Nasdaq 100, but what Nasdaq used to be in the 1990s.

The Federal Reserve will reverse course on interest-rate policy next year by yanking down borrowing rates in the face of weaker activity in the US economy, disruptive-tech investor Cathie Wood told Bloomberg TV.

“We’re getting all kinds of signals that the economy is very weak,” which will prompt the Fed to start rate cuts in 2023, she said Monday.

 

Take Away

The well-followed manager always has strong convictions, they are often contrary to popular opinion. These forecasts have both served her firm and investors well and have caused disappointment when the volatile innovative sector is giving back gains.

She said that she will stay 100% invested as the industries and companies her funds are most heavily weighted in will be the kind of companies that help resolve issues weighing on consumers and economies today.

Did you know Channelchek has no paywall – and never will? Take the time to sign-up now for regular emails on quality research of innovative companies and insightful articles and ideas.

Paul Hoffman

Managing Editor, Channelchek

Suggested Content



Cathie Wood Thinks if There is No Blood in Your Street, You Should Move



Michael Burry vs Cathie Wood is Not an Even Competition




Peter Lynch Echoes Michael Burry’s Warning About Index Investments



A Look at Global Inflation and its Causes


https://www.bloomberg.com/news/videos/2022-08-08/cathie-wood-on-the-fed-economy-coinbase-tesla-video

https://www.econoday.com/august-boe-mpc-preview-time-for-a-change-of-gear/

Stay up to date. Follow us:

 

Release – Harte Hanks to Present at the 12th Annual Midwest IDEAS Investor Conference on August 24th and 25th in Chicago, IL



Harte Hanks to Present at the 12th Annual Midwest IDEAS Investor Conference on August 24th and 25th in Chicago, IL

Research, News, and Market Data on Harte Hanks

CHELMSFORD, MA / ACCESSWIRE / August 9, 2022 / Harte Hanks, Inc. (NASDAQ:HHS), a leading global customer experience company focused on bringing companies closer to customers for nearly 100 years, today announced that Brian Linscott,its Chief Executive Officer, will present at the Midwest IDEAS Investor Conference on Wednesday, August 24, 2022, at The Gwen in Chicago, IL. Harte Hanks’s presentation is scheduled to begin at 11:00am CT. The presentation will be webcast and may be accessed through the conference host’s main website: https://www.threepartadvisors.com/midwest and in the investor relations section of the company’s website: https://investors.hartehanks.com/.

About IDEAS Investor Conferences

The mission of the IDEAS Conferences is to provide independent regional venues for quality companies to present their investment merits to an influential audience of investment professionals. Unlike traditional bank-sponsored events, IDEAS Investor Conferences are “SPONSORED BY INVESTORS. FOR
INVESTORS.”
 and for the benefit of regional investment communities. Conference sponsors collectively have more than $200 billion in assets under management and include: 1102 Partners, Adirondack Research and Management, Allianz Global Investors: NFJ Investment Group, Ariel Investments, Aristotle Capital Boston, Barrow Hanley Mewhinney & Strauss, BMO Global Asset Management, Constitution Research & Management, Inc., Fidelity Investments, First Wilshire Securities Management, Inc., Gamco Investors, Granahan Investment Management, Great Lakes Advisors, Greenbrier Partners Capital Management, LLC, GRT Capital Partners, LLC, Hodges Capital Management, Ironwood Investment Management, Keeley Teton Advisors, Luther King Capital Management, Marble Harbor Investment Counsel, North Star Investment Management, Perritt Capital Management, Punch & Associates, Westwood Holdings Group, Inc., and William Harris Investors.

The IDEAS Investor Conferences are held annually in Boston, Chicago and Dallas and are produced by Three Part Advisors, LLC. Additional information about the events can be located at www.IDEASconferences.com.

If interested in participating or learning more about the IDEAS conferences, please contact Lacey Wesley at (817) 769 -2373 or lwesley@threepa.com.

About Harte Hanks:

Harte Hanks (Nasdaq:HHS) is a leading global customer experience company whose mission is to partner with clients to provide them with CX strategy, data-driven analytics and actionable insights combined with seamless program execution to better understand, attract and engage their customers. Using its unparalleled resources and award-winning talent in the areas of Customer Care, Fulfillment and Logistics, and Marketing Services, Harte Hanks has a proven track record of driving results for some of the world’s premier brands, including Bank of America, GlaxoSmithKline, Unilever, Pfizer, HBOMax, Volvo, Ford, FedEx, Midea, Sony and IBM among others. Headquartered in Chelmsford, Massachusetts, Harte Hanks has over 2,500 employees in offices across the Americas, Europe, and Asia Pacific.

Investor Relations Contact:

FNK IR
Rob Fink or Tom Baumann
646.809.4048 / 646.349.6641
HHS@fnkir.com

For media inquiries, contact Jennifer London at Jen.London@HarteHanks.com

SOURCE: Harte Hanks, Inc.

 

Release – Defense Metals Diamond Drilling Update Infill and Exploration Drilling Complete And Pit Slope Geotechnical Drilling Underway



Defense Metals Diamond Drilling Update Infill and Exploration Drilling Complete And Pit Slope Geotechnical Drilling Underway

News, and Market Data on Defense Metals

VANCOUVER, BC, Aug. 9, 2022 /CNW/ – Defense Metals Corp. (“Defense
Metals
” or the “Company“) (TSXV: DEFN) (OTCQB: DFMTF) (FSE: 35D) is pleased to provide an update for its ongoing diamond drilling at its Wicheeda Rare Earth Element (REE) deposit. The 2022 resource infill and exploration diamond drill campaign is now complete and pit slope geotechnical drilling underway.

Figure 1. Wicheeda REE Deposit PEA Ultimate Pit Geotechnical Drill Plan (CNW Group/Defense Metals Corp.)

A total of 12 diamond drill holes totalling over 3,500 metres have been drilled to date within the northern and central areas of the Wicheeda REE Deposit preliminary economic assessment (PEA) mine plan ultimate pit area, with initial assays results from the earliest drill holes expected during September or October 2022.

All materials, instrumentation, and technical personnel have now been mobilized to site to commence geotechnical drilling for the purpose of open pit slope design optimization. A total of 5 geotechnical drill holes targeting the north, west, south, and east high walls of the Wicheeda PEA mine plan ultimate pit are planned (Figure 1). Data collection will include oriented drill core, field point load and laboratory-based intact rock and discontinuity strength testing, vibrating wire piezometer, and standpipe piezometer installation for hydrogeological investigations.

Kristopher Raffle, P.Geo., Director and QP of Defense Metals commented: “Defense
Metals is very pleased with the progress of the 2022 infill and exploration
drilling to date, and we look forward to gathering important pit slope
geotechnical data to support future Wicheeda REE Deposit advanced economic
studies.”

Management Site Visit

Concurrent with the commencement of geotechnical investigations Defense Metals’ management has arranged for a Wicheeda field visit during the week of August 15, 2022, to accompany strategic interested parties and capital market analysts.

About the Wicheeda REE
Property

The 100% owned 4,244-hectare Wicheeda REE Property, located approximately 80 km northeast of the city of Prince George, British Columbia, is readily accessible by all-weather gravel roads and is near infrastructure, including power transmission lines, the CN railway, and major highways.

The Wicheeda REE Project yielded a robust 2021 PEA that demonstrated an after-tax net present value (NPV@8%) of $517 million, and 18% IRR1. A unique advantage of the Wicheeda REE Project is the production of a saleable high-grade flotation-concentrate. The PEA contemplates a 1.8 Mtpa (million tonnes per year) mill throughput open pit mining operation with 1.75:1 (waste:mill feed) strip ratio over a 19 year mine (project) life producing and average of 25,423 tonnes REO annually. A Phase 1 initial pit strip ratio of 0.63:1 (waste:mill feed) would yield rapid access to higher grade surface mineralization in year 1 and payback of $440 million initial capital within 5 years.

____________________________

1 Independent Preliminary Economic Assessment for the Wicheeda Rare Earth Element Project, British Columbia, Canada, dated January 6, 2022, with an effective date of November 7, 2021, and prepared by SRK Consulting (Canada) Inc. is filed under Defense Metals Corp.’s Issuer Profile on SEDAR (www.sedar.com).

Qualified Person

The scientific and technical information contained in this news release as it relates to the Wicheeda REE Project has been reviewed and approved by Kristopher J. Raffle, P.Geo. (BC) Principal and Consultant of APEX Geoscience Ltd. of Edmonton, AB, a director of Defense Metals and a “Qualified Person” as defined in NI 43-101. Mr. Raffle verified the data disclosed which includes a review of the sampling, analytical and test data underlying the information and opinions contained therein.

About Defense Metals
Corp.

Defense Metals Corp. is a mineral exploration and development company focused on the acquisition, exploration and development of mineral deposits containing metals and elements commonly used in the electric power market, defense industry, national security sector and in the production of green energy technologies, such as, rare earths magnets used in wind turbines and in permanent magnet motors for electric vehicles. Defense Metals owns 100% of the Wicheeda Rare Earth Element Property located near Prince George, British Columbia, Canada. Defense Metals Corp. trades in Canada under the symbol “DEFN” on the TSX Venture Exchange, in the United States, under “DFMTF” on the OTCQB and in Germany on the Frankfurt Exchange under “35D”.

For further information,
please contact:

Todd Hanas, Bluesky Corporate Communications Ltd.
Vice President, Investor Relations
Tel: (778) 994 8072
Email: 
todd@blueskycorp.ca

Neither
the TSX Venture Exchange nor its Regulation Services Provider (as that term is
defined in the policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this news release.

Cautionary Statement
Regarding “Forward-Looking” Information

This news release contains “forward?looking information or statements” within the meaning of applicable securities laws, which may include, without limitation, statements relating to advancing the Wicheeda REE Project, drill results including anticipated timeline of such results/assays, the Company’s plans for its Wicheeda REE Project, expanded resource and scale of expanded resource, expected results and outcomes, Wicheeda site visit and expected outcomes, the technical, financial and business prospects of the Company, its project and other matters. All statements in this news release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, including the price of rare earth elements, the anticipated costs and expenditures, the ability to achieve its goals, that general business and economic conditions will not change in a material adverse manner, that financing will be available if and when needed and on reasonable terms. Such forward-looking information reflects the Company’s views with respect to future events and is subject to risks, uncertainties and assumptions, including the risks and uncertainties relating to the interpretation of exploration results, risks related to the inherent uncertainty of exploration and cost estimates, the potential for unexpected costs and expenses and those other risks filed under the Company’s profile on SEDAR at www.sedar.com. While such estimates and assumptions are considered reasonable by the management of the Company, they are inherently subject to significant business, economic, competitive and regulatory uncertainties and risks. Factors that could cause actual results to differ materially from those in forward looking statements include, but are not limited to, continued availability of capital and financing and general economic, market or business conditions, adverse weather and climate conditions, failure to maintain or obtain all necessary government permits, approvals and authorizations, failure to maintain community acceptance (including First Nations),  risks relating to unanticipated operational difficulties (including failure of equipment or processes to operate in accordance with specifications or expectations, cost escalation, unavailability of personnel, materials and equipment, government action or delays in the receipt of government approvals, industrial disturbances or other job action, and unanticipated events related to health, safety and environmental matters), risks relating to inaccurate geological and engineering assumptions, decrease in the price of rare earth elements, the impact of Covid-19 or other viruses and diseases on the Company’s ability to operate, an inability to predict and counteract the effects of COVID-19 on the business of the Company, including but not limited to, the effects of COVID-19 on the price of commodities, capital market conditions, restriction on labour and international travel and supply chains, loss of key employees, consultants, or directors, increase in costs, delayed drilling results, litigation, and failure of counterparties to perform their contractual obligations. The Company does not undertake to update forward?looking statements or forward?looking information, except as required by law.

SOURCE Defense Metals Corp.


Release – Eskay Mining Discovers a New VMS Center at Jeff North and Intercepts Polymetallic VMS Mineralization in Two Areas Along TV-Jeff Corridor



Eskay Mining Discovers a New VMS Center at Jeff North and Intercepts Polymetallic VMS Mineralization in Two Areas Along TV-Jeff Corridor

Research, News and Market Data on Eskay Mining

TORONTO, ON / ACCESSWIRE / August 9, 2022 / Eskay Mining Corp. (“Eskay” or the “Company”) (TSXV:ESK)(OTCQX:ESKYF)(Frankfurt:KN7) (WKN:A0YDPM) is pleased to announce discovery of a new volcanogenic massive sulfide (“VMS”) center at Jeff North as well as recent drill intercepts of polymetallic mineralization in two areas along the TV-Jeff corridor, part of its 100% controlled Consolidated Eskay project, British Columbia. As of this release, over 13,000m of diamond drilling has been undertaken in numerous drill holes along 3.7km of strike at TV-Jeff. Diamond drilling also continues at the Scarlet Ridge area, subject of a Company news release dated July 27, 2022. To date, the Company has completed approximately 15,600m of diamond core drilling, approximately 52% of the 30,000m planned to be completed in 2022. Drill production remains on target to reach this aggressive goal with four drills fully operational.

“As with the Scarlet Ridge-Tarn Lake VMS corridor, the TV-Jeff VMS corridor is proving itself to be another large VMS complex with sulfide mineralization focused along multiple syn-volcanic fault structures each closely associated with intense hydrothermal alteration of volcanic rocks”, commented Dr. John DeDecker, Eskay Mining’s VP of Exploration. “The discovery of Jeff North now extends the strike length of the known TV-Jeff VMS corridor to 3.7km. Importantly, recent drill holes completed in two areas have yielded intercepts of polymetallic sulfide mineralization with abundant chalcopyrite and sphalerite. Spot XRF readings taken from core indicates promising pathfinder element support including silver from this style of mineralization. Also encouraging, anomalous geochemical results recently received from soil samples collected at the very start of the 2022 exploration season indicate mineralization potentially extends another 2 km further north from Jeff North. We are optimistic that multiple other VMS targets we have recently identified along the TV-Jeff trend will prove mineralized, and we continue to grow confident about the potential for the Consolidated Eskay project to host an entire VMS district.”

Jeff North

Drilling at Jeff North targeted a large conductive SkyTEM anomaly coincident with a ridge of silicified peperitic basalt displaying strong Ag-in-soil anomalies from samples collected during the 2021 program. Strong VMS stockwork mineralization encountered in recent drilling at Jeff North lies 600m north of Jeff and extends at least 700m northwards along strike remaining open to the north. Some stockwork intervals are distinctly polymetallic displaying abundant sphalerite and chalcopyrite in addition to the ubiquitous pyrite. This mineralogy coupled with the presence of strong pathfinder elements including Ag, As, Sb, Cu, Zn, and Pb as detected by handheld XRF provide encouragement for presence of Au and Ag, both of which must be assayed for accurate measurement.Core is being logged, split and sampled in preparation for submittal for assaying.

Jeff North Drilling Highlights

  • At present, drilling at Jeff North has ceased and the focus has moved onto TV, the area between TV and Jeff (Figures 1 and 2), and Scarlet Ridge. This said, Eskay is prepared to follow up with drilling at Jeff North late-season should assays confirm this to be a significant new discovery.
  • Jeff North represents a new VMS discovery beginning 600m north of Jeff and extending at least 700m northwards. Sulfide mineralization is hosted by intensely silicified peperitic basalt and andesite flows (Figures 3 and 4). Mineralization remains open to the north as well as down-dip.
  • J22-118 intercepted a 12.7m interval of polymetallic sulfide mineralization hosted within a silica-rich hydrothermal breccia and surrounding silicified mudstone (Figures 5 and 6). Sulfide mineralization includes abundant chalcopyrite and sphalerite. The presence of chalcopyrite with intense silicification suggests the proximity to a higher temperature VMS feeder zone than those encountered at TV and Jeff.
  • Handheld XRF analyses of sulfide mineralization in several drill holes from Jeff North show high concentrations of the pathfinder elements Ag, As, Sb, Cu, Zn, and Pb.
  • Early results from the 2022 soil sampling program show Ag and Hg anomalism extends 2km further north than hole J22-99 (Figure 9), the northernmost drill hole completed at Jeff North. Given that the Jeff North target was recognized as a SkyTEM conductivity high with an accompanying soil geochemical anomaly, Eskay’s exploration team is optimistic that the Jeff North VMS system extends further northward. Soil sampling over a large SkyTEM conductive high approximately 1.8km north of Jeff North is currently underway.
  • J22-122 intercepted a 9.0 m interval of polymetallic sulfide mineralization hosted by intensely silicified andesitic peperite and associated mudstone (Figures 7 and 8). Polymetallic mineralization in both J22-118 and J22-122 occur at an equivalent horizon to the lower stockwork zone at Jeff 125 m south of J22-122.

Commencement of Drilling at TV

  • Drilling has commenced at TV focusing on expanding upon the core body of mineralization identified in 2021 drilling. Planned drill holes will test extensions of TV mineralization further down-dip, along strike to the north and south, and up stratigraphic section.
  • Testing of nearby IP-resistivity and SkyTEM targets is also scheduled. Based on past success of targeting VMS mineralization using SkyTEM and soil data at Jeff North, Jeff, and TV, the Eskay team is optimistic that a cluster of SkyTEM conductivity highs surrounding TV will lead to discovery of additional VMS mineralization.
  • The first 2022 drill hole at TV, TV22-84, intercepted approximately 40m of stockwork sulfide mineralization 65m down-dip from TV21-54, a very promising indication the system remains open in this direction (Figures 10 and 11).

To date, Eskay Mining has completed approximately 15,600m of diamond core drilling, approximately 52% of the 30,000m planned for 2022. Thus far, drilling has occurred around the area called Jeff North, Scarlet Ridge and now, at TV. At present, four drills are fully operational and drill production is on track to reach Eskay’s aggressive goal of 30,000 m.

Dr. Quinton Hennigh, P. Geo., a Director of the Company and its technical adviser, a qualified person as defined by National Instrument 43-101, has reviewed and approved the technical contents of this news release.

About Eskay Mining Corp:

Eskay Mining Corp (TSX-V:ESK) is a TSX Venture Exchange listed company, headquartered in Toronto, Ontario. Eskay is an exploration company focused on the exploration and development of precious and base metals along the Eskay rift in a highly prolific region of northwest British Columbia known as the “Golden Triangle,” 70km northwest of Stewart, BC. The Company currently holds mineral tenures in this area comprised of 177 claims (52,600 hectares).

All material information on the Company may be found on its website at www.eskaymining.com and on SEDAR at www.sedar.com.

For further information, please contact:

Mac Balkam
President & Chief Executive Officer

T: 416 907 4020
E: 
Mac@eskaymining.com

Neither the
TSX Venture Exchange nor its Regulation Services Provider (as that term is
defined in the policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.

Forward-Looking
Statements: This Press Release contains forward-looking statements that
involve risks and uncertainties, which may cause actual results to differ
materially from the statements made. When used in this document, the words
“may”, “would”, “could”, “will”, “intend”, “plan”, “anticipate”, “believe”,
“estimate”, “expect” and similar expressions are intended to identify
forward-looking statements. Such statements reflect our current views with
respect to future events and are subject to risks and uncertainties. Many
factors could cause our actual results to differ materially from the statements
made, including those factors discussed in filings made by us with the Canadian
securities regulatory authorities. Should one or more of these risks and
uncertainties, such as actual results of current exploration programs, the
general risks associated with the mining industry, the price of gold and other
metals, currency and interest rate fluctuations, increased competition and
general economic and market factors, occur or should assumptions underlying the
forward looking statements prove incorrect, actual results may vary materially
from those described herein as intended, planned, anticipated, or expected. We
do not intend and do not assume any obligation to update these forward-looking
statements, except as required by law. Shareholders are cautioned not to put
undue reliance on such forward-looking statements.


Full Press Release with appendix images available at
eskaymining.com


Should Medical Cannabis Patients be Forbidden from Owning Firearms?



Image Credit: Raymond Clark (Flickr)


The DOJ’s Case Against Allowing Medical Marijuana Users from Purchasing a Gun

Is it  “dangerous to trust regular marijuana users to exercise sound judgment” with firearms? The Department of Justice responded to a lawsuit asking the court to dismiss a medical marijuana lawsuit on Monday (August 7). The suit was filed by an agriculture official in Florida. The circumstances involved patients using cannabis; it claims that the federal government is unconstitutionally depriving them of their Second Amendment right to purchase and possess firearms. The DOJ asked a federal court to dismiss the lawsuit claiming it seeks to overturn policy involving medical marijuana users and their inability to own firearms.

The suit was filed by Agriculture and Consumer Services Commissioner Nikki Fried (D), who is a candidate in Florida for governor. It made a unique legal argument that a congressional spending rider prevents the use of Justice Department funds to interfere in the implementation of medical marijuana programs.

Presently, in order to buy a gun, citizens are required to fill out a federal form that explicitly asks about the use of (federally) illegal drugs. Applicants that use cannabis, which is legal for medical use in Florida, are not allowed to purchase a gun and could face up to five years in prison if they lie on the application.

This case has national implications and is of interest not just to those that benefit from medical cannabis but also to investors in medical marijuana.


Components of the Case

The suit alleges a federal rule that bars medical marijuana patients from having guns is unconstitutional.

In its motion to dismiss the case or secure a favorable judgment, the U.S. DOJ claimed that the policies being challenged by the lawsuit only apply to people who use illegal drugs, in this case, cannabis. Therefore, Second Amendment rights of law-abiding citizens are not barred.

“These laws merely prevent drug users who commit federal crimes by unlawfully possessing drugs from possessing and receiving firearms, and only for so long as they are actively engaged in that criminal activity,” the DOJ brief to dismiss claimed.

The DOJ referenced Florida’s own medical consent form accepted by Florida marijuana regulators; the DOJ noted that it warns, that marijuana “impairs judgment, cognition and physical coordination, including ‘the ability to think, judge and reason.'” The DOJ added that there was a deeply rooted practice in American law and policy of not allowing dangerous or lawbreaking individuals to possess firearms.

“A long tradition exists of viewing intoxication as a condition that renders firearms possession dangerous, and accordingly restricting the firearms rights of those who become intoxicated,” the brief said.

In the complaint, filed April 20, 2022, the plaintiffs claim the central question in the case is whether the physical and/or psychological effects of medical marijuana render users “sufficiently dangerous or violent” so that possession or use of a firearm would cause concern.

They further referenced a study that demonstrated that medical marijuana has no such effect. The plaintiffs referenced the 2013, Office of National Drug Control Policy study that concluded there was “little support for a contemporaneous, causal relationship between the use of marijuana ‘and either violent or property crime.'”

In its Monday brief, the DOJ countered that “marijuana users with firearms pose a danger comparable to, if not greater than, other groups that have historically been disarmed,” in part because cannabis remains federally illegal.

The government argued further that Nicole Fried, the state Department of Agriculture and Consumer Services commissioner who brought the lawsuit, had no standing to bring the action since she did not allege her right to possess firearms had been infringed.

The DOJ is seeking the dismissal of all claims.

The case is Fried et al. v. Garland et al., case number 4:22-cv-00164, in the U.S. District Court for the Northern District of Florida.


Take Away

It is presumed by many that marijuana for medical use and study will at some point be
dropped as a schedule 1 drug. Despite a number of bills in the house and the Senate that, if passed and signed into law, would accomplish reclassification, to date, marijuana is still illegal on a federal level.

The status is complicated by the fact that 37 of the 50 states allow medical use for qualified individuals. The case filed by Florida’s Agricultural Secretary Fried attempts to still uphold second amendment rights to those approved for and using medical marijuana in Florida. The U.S. Department of Justice is opposed.

There is no indication whether a change in federal legal status would change, in the DOJ’s mind, the dangers of allowing firearm ownership to these patients.

Paul Hoffman

Managing Editor, Channelchek

Suggested Content



Senate Marijuana Bill Expected Before Summer Break



Lawmakers and Insider Trading Laws




Cannabis Vape Distribution Limited Under New Law



Evaluating Opportunity With the iPhone New Marijuana Policy


Sources

https://www.orlandosentinel.com/news/os-ne-prem-nikki-fried-medical-marijuana-20210611-dzil5daz7rfw7k7mjf6szxpo7y-story.html

https://www.marijuanamoment.net/florida-official-sues-biden-administration-over-gun-rights-for-medical-marijuana-patients-on-4-20/

https://www.law360.com/health/articles/1519290/doj-says-medical-pot-patients-have-no-right-to-bear-arms?copied=1

https://unicourt.com/case/pc-db5-fried-et-al-v-garland-et-al-1182072

https://www.dea.gov/sites/default/files/2020-06/Marijuana-Cannabis-2020_0.pdf

Stay up to date. Follow us:

 

Gray Television (GTN) – Political Better Than Expected

Monday, August 08, 2022

Gray Television (GTN)
Political Better Than Expected

Gray Television is a multimedia company headquartered in Atlanta, Georgia. We are the nation’s largest owner of top-rated local television stations and digital assets in the United States. Our television stations serve 113 television markets that collectively reach approximately 36 percent of US television households. This portfolio includes 80 markets with the top-rated television station and 100 markets with the first and/or second highest rated television station. We also own video program companies Raycom Sports, Tupelo Honey, PowerNation Studios and Third Rail Studios.

Michael Kupinski, Director of Research, Noble Capital Markets, Inc.

Patrick McCann, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Q2 exceeds expectations. The company reported quarterly revenue of $868 million, 11% above our estimate of $782 million. Adj. EBITDA was also strong, at $309 million, which beat our estimate of $280 million by 10.4%.

Inundated with Political. The skeptical management became a believer that Political could meet or exceed 2020 levels. Management raised 2022 Political advertising forecast from $575 million to $652 million. …

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.